IO Biotech Company

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Technology: Peptides and Proteins
Industry: Peptides and Proteins
Headquarters: Copenhagen, Hovedstaden, Denmark
Founded Date: 2014-12-23
Employees Number: 11-50
Funding Status: IPO
Investors Number: 16
Total Funding: 159883430
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-10-07
Last Funding Type: Series C

Visit Website
Register and Claim Ownership